Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant

http://dx.doi.org/10.1289/ehp.1306615



Table 3. Number of reported and validateda primary cancer cases among the cohort (n = 32,254).
Cancer No. reported No. reported (had a medical record reviewed or a cancer registry entry) No. validated
[n (%)]
aValidated cases were limited to participants who reported the cancer and were subsequently confirmed either by Ohio/West Virginia cancer registry or medical record review; participants reported whether a doctor had ever told them they had a cancer or malignancy of any kind. bThese 3,589 cancers were self-reported by 3,292 participants; some ­participants reported more than one cancer type. cThese 2,507 cancers are among 2,361 participants.
Bladder 115 115 111 (96.5)
Brain 33 31 23 (69.7)
Breast 608 600 581 (95.6)
Cervical 383 245 22 (5.7)
Colorectal 311 297 276 (88.7)
Esophagus 21 19 15 (71.4)
Kidney 124 117 113 (91.1)
Leukemia 79 71 69 (87.3)
Liver 18 15 10 (55.6)
Lung 133 124 113 (85.0)
Lymphoma 164 158 142 (86.6)
Melanoma 519 414 245 (47.2)
Oral 35 34 20 (57.1)
Ovarian 87 65 43 (49.4)
Pancreatic 35 31 26 (74.3)
Prostate 515 476 458 (88.9)
Soft tissue 25 19 17 (68.0)
Stomach 29 24 12 (41.4)
Testicular 32 21 19 (59.4)
Thyroid 98 97 87 (88.8)
Uterine 225 173 105 (46.7)
Total 3,589b 3,146 2,507c (69.9)